Sanofi India concludes sale of commercial property at Mumbai for Rs 111 crore

21 Nov 2015 Evaluate

Sanofi India has completed the sale of its commercial property, being land admeasuring 5493.1 square meters bearing Survey No. 54-A Hissa No. 2 and C.T.S. No. 18 of Village Chakala, Andheri (East), Mumbai along with the building known as ‘Aventis House’ on November 20, 2015, upon fulfillment of the conditions.

The company has received the entire sale consideration of Rs111.00 crore from the purchaser. The board of directors earlier at their meeting held on July 21, 2015 had approved for the same.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.



Sanofi India Share Price

6052.95 -28.20 (-0.46%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.